Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

News | Heart Valve Technology

April 27, 2022 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall for the Medtronic Harmony deliv ...

Home April 27, 2022
Home
News | Womens Cardiovascular Health

April 25, 2022 – Advancements in techniques and treatment have transformed care for patients with cardiovascular disease ...

Home April 25, 2022
Home
News | Left Atrial Appendage (LAA) Occluders

April 12, 2022 –  Patients who had leakage to the left atrial appendage due to incomplete device sealing after left ...

Home April 12, 2022
Home
News | Atrial Fibrillation

April 12, 2022 –  iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...

Home April 12, 2022
Home
News | Structural Heart

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...

Home April 07, 2022
Home
News | Heart Failure

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

Home April 01, 2022
Home
News | ACC

April 1, 2022 —  Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
News | Structural Heart

March 31, 2022 – Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home March 31, 2022
Home
News | Structural Heart

March 24, 2022 — HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic ...

Home March 24, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of ...

Home March 04, 2022
Home
News | Heart Valve Technology

March 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can ...

Home March 02, 2022
Home
News | Heart Valve Technology

February 28, 2022 - Foldax, Inc. has announced the presentation of results from the first animal study of its ...

Home February 28, 2022
Home
Subscribe Now